National Cancer Institute; Notice of Closed Meetings, 23739 [2016-09315]
Download as PDF
23739
Federal Register / Vol. 81, No. 78 / Friday, April 22, 2016 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Type of respondent
Form name
Private Applicators ................
Private Applicators ................
Controls .................................
Controls .................................
Controls .................................
Controls .................................
Controls .................................
Controls .................................
IA/NC BEEA Consent for AMG Farm Visit ..
BEEA Pre-Farm Visit Script .........................
BEEA CATI Control Eligibility Script ............
IA/NC BEEA Control Home Visit Consent ...
IA/NC BEEA Pre-Visit Show Card ...............
IA/NC BEEA Paper/Pen Dust Questionnaire
BEEA REG Pre-Visit Script ..........................
BEEA Control Home Visit CAPI, Blood,
Buccal cell, Urine, & Dust.
‘Life in a Day’ Smartphone App Consent
and Setup.
‘Life in a Day’ Smartphone Application ........
Phase IV Follow-up CAWI, CATI, or Paper/
pen.
Phase IV Follow-up CAWI, CATI, or Paper/
pen.
Phase IV Follow-up CAWI, CATI, or Paper/
pen.
Private Applicators ................
Private Applicators ................
Private Applicators ................
Spouses ................................
Proxy .....................................
Total ...............................
.......................................................................
Dated: April 18, 2016.
Jane M. Lambert,
Project Clearance Liaison, NIEHS.
[FR Doc. 2016–09296 Filed 4–21–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
F—Institutional Training and Education.
Date: June 14, 2016.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W030, Rockville, MD 20850, (Telephone
Conference Call).
VerDate Sep<11>2014
19:18 Apr 21, 2016
Jkt 238001
5/60
2/60
20/60
5/60
5/60
10/60
2/60
90/60
1
1
72
6
6
11
2
101
78
1
20/60
26
78
13,855
30
1
10/60
25/60
390
5,773
10,201
1
25/60
4,250
635
1
15/60
159
27,139
29,641
........................
11,438
[FR Doc. 2016–09315 Filed 4–21–16; 8:45 am]
Frm 00066
Fmt 4703
Sfmt 4703
Total annual
burden hours
1
2
1
1
1
1
1
1
Dated: April 18, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
PO 00000
Average time
per response
(in hours)
16
16
215
67
67
67
67
67
Contact Person: Timothy C. Meeker, M.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 9609 Medical Center Drive, Room
7W624, Bethesda, MD 20892–9750, 240–276–
6464, meekert@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel,
Comprehensive Partnerships to Advance
Cancer Health Equity (CPACHE) (U54).
Date: June 15–16, 2016.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Yisong Wang, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, 9609 Medical
Center Drive, Room 7W240, Bethesda, MD
20892–9750, 240–276–7157, yisong.wang@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
BILLING CODE 4140–01–P
Number of
responses per
respondent
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
[1651–0123]
Agency Information Collection
Activities: Regulations Relating to
Recordation and Enforcement of
Trademarks and Copyrights
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: 30-Day notice and request for
comments; Extension of an existing
collection of information.
AGENCY:
U.S. Customs and Border
Protection (CBP) of the Department of
Homeland Security will be submitting
the following information collection
request to the Office of Management and
Budget (OMB) for review and approval
in accordance with the Paperwork
Reduction Act: Regulations Relating to
Recordation and Enforcement of
Trademarks and Copyrights (Part 133 of
the CBP Regulations). This is a proposed
extension of an information collection
that was previously approved. CBP is
proposing that this information
collection be extended with no change
to the burden hours or to the
information collected. This document is
published to obtain comments from the
public and affected agencies.
DATES: Written comments should be
received on or before May 23, 2016 to
be assured of consideration.
ADDRESSES: Interested persons are
invited to submit written comments on
this proposed information collection to
SUMMARY:
E:\FR\FM\22APN1.SGM
22APN1
Agencies
[Federal Register Volume 81, Number 78 (Friday, April 22, 2016)]
[Notices]
[Page 23739]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-09315]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Initial Review
Group; Subcommittee F--Institutional Training and Education.
Date: June 14, 2016.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W030, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Timothy C. Meeker, M.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, 9609 Medical
Center Drive, Room 7W624, Bethesda, MD 20892-9750, 240-276-6464,
meekert@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Comprehensive Partnerships to Advance Cancer Health Equity
(CPACHE) (U54).
Date: June 15-16, 2016.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue,
Bethesda, MD 20814.
Contact Person: Yisong Wang, Ph.D., Scientific Review Officer,
Special Review Branch, Division of Extramural Activities, National
Cancer Institute, 9609 Medical Center Drive, Room 7W240, Bethesda,
MD 20892-9750, 240-276-7157, yisong.wang@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: April 18, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-09315 Filed 4-21-16; 8:45 am]
BILLING CODE 4140-01-P